TriSalus Life Sciences, Inc. (TLSI) 8-K Current Report: March 5, 2026
Filed: March 5, 2026
Health Care
Surgical & Medical Instruments & ApparatusTriSalus Life Sciences, Inc. (TLSI) 8-K current report filed with SEC EDGAR on March 5, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
TriSalus Life Sciences, Inc. 8-K Mar 5, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 financial results announced March 5, 2026 — details in Exhibit 99.1
- • Filing furnished, not "filed" — limits legal liability under Exchange Act Section 18
- • Actual revenue, earnings, and key metrics available only in attached press release (Exhibit 99.1)
Get deeper insights on TriSalus Life Sciences, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.